May, 19th is the Inflammatory Bowel Disease (IBD) Day. Abdominal pain, bloating … In 2021, up to 40% of the wold population is still suffering from functional gastrointestinal disorders.
These disorders can have a significant impact on daily life and affect the quality of life. About one out of two people affected feel that they are losing control over their lives due to those gastrointestinal symptoms (bad body image, interference with daily activities… ).
The disorders are characterised by common gastrointestinal symptoms such as abdominal pain and bloating associated with transit disorders. The characteristic symptoms of functional gastrointestinal disorders are also present in a significant proportion of people with inflammatory bowel disease.
Saccharomyces cerevisiae I-3856, the unique probiotic yeast to manage abdominal pain, bloating and gut health
In order to offer a complete solution, the probiotic yeast Saccharomyces cerevisiae CNCM I-3856 has been developed over 10 years ago. This unique and patented strain, marketed today under the brand ibSium®, has been studied in 4 clinical trials carried out on over 1100 volunteers.
These studies have demonstrated the benefits of this probiotic yeast on abdominal pain and bloating as well as on transit disorders, in case of constipation or diarrhea. In addition, a significant improvement in quality of life was measured in volunteers who received S. cerevisiae CNCM I-3856 for 8 weeks. S. cerevisiae CNCM I-3856 represents a complete solution with clinically proven efficacy for gastrointestinal symptoms management and an optimized gut health and quality of life.
DISCOVER ALL OUR LATEST NEWS
Support Longevity with the Premium Quality Methylator Agent: Exclusive Interview with Prof. Fuso, Ph.D
What is epigenetics, and what is its link to methylation?
New research shows increasing bone mineral density by 3% equates
This year’s SupplySide West set the stage for our first-of-its-kind,